features: Colorectal Cancer

MOUNTAINEER: Tucatinib plus trastuzumab demonstrates good efficacy for the treatment of HER2-positive metastatic colorectal cancer

In the U.S., colorectal cancer (CRC) is the third leading cause of cancer-related deaths and is expected to lead to…

Highlights from ASCO 2022

VJOncology are excited to present our top picks from the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting!

Top 5 in GI from ASCO 2021

VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!

ASCO GI 2021 Highlights

VJOncology are excited to present some key abstracts and trial updates announced at this year’s virtual ASCO GI meeting!

Positive TAPUR data in advanced CRC presented at GI Cancer Symposium

The 2020 Gastrointestinal (GI) Cancers Symposium presented the latest data in the field, including findings from the Targeted Agent and…